{"disease":{"id":"gvhd-chronic","name":"gvhd chronic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03042676","title":"Electronic Database for the Follow up of the ATG_FamilyStudy","phase":"","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06462365","title":"Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tr1X, Inc.","has_results":false},{"nct_id":"NCT04884204","title":"Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04930562","title":"Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"BioNova Pharmaceuticals (Shanghai) LTD.","has_results":true},{"nct_id":"NCT04473911","title":"Haplo Peripheral Blood Sct In GVHD Prevention","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Zachariah Michael DeFilipp","has_results":false},{"nct_id":"NCT02611180","title":"Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT01523821","title":"Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT05401955","title":"Physiotherapy and Therapeutic Exercise Program in Graft-versus-host Disease (GvHD)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"University of Salamanca","has_results":false},{"nct_id":"NCT07350057","title":"A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04107675","title":"A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Zambon SpA","has_results":true},{"nct_id":"NCT04932564","title":"Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell Transplant","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Tata Memorial Centre","has_results":false},{"nct_id":"NCT04745637","title":"Managed Access Programs for INC424, Ruxolitinib","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}